Reading, United Kingdom--(ENEWSPF)--21 January 2011. The administration of the nonpsychotropic cannabinoid CBD (cannabidiol) significantly reduces the incidences and severity of seizures, according to preclinical data published online in Seizure: The Journal of the British Epilepsy Association.
Investigators at the University of Reading, School of Pharmacy, in the United Kingdom assessed the anticonvulsant activity of CBD (administered in 1, 10, and . . .